The legacy of the late Steve Jobs is sure to be admired by the innovators of tomorrow, and among his many business talents was his ability to protect and leverage intellectual assets for unparalleled success.

The U.S. Chamber of Commerce's Global Intellectual Property Center recently debuted a new multimedia platform intended to spotlight the significant role of intellectual property in the nation's economic rebound.

A recently released report from the Organization for Economic Cooperation and Development suggests that the declining quality of patent filings observed in the past two decades may now be stifling innovation.

The latest report from Boston University researchers highlighted the gravity of patent lawsuits, suggesting that inventors may have lost as much as $500 billion in legal battles over the past two decades.

The World Intellectual Property Organization recently released its latest summary of facts and figures synthesized from 90 IP offices around the world. The comprehensive report contains several significant revelations concerning patents, utility models and industrial designs. But the findings that have attracted the most attention relate to the growing importance of trademarking.

Intellectual property discussions take high priority in the pharmaceutical industry as decisions affect not only business interests, but the health and safety of consumers. In an effort to address these concerns, the Pharmaceutical Industry Labor Management Association recently vowed to redouble its efforts for fraud prevention and intellectual property protection.

In a move reflective of the technology giant's recent efforts to incorporate intellectual property into its competitive strategy, Google has purchased more than 1,000 additional patents from IBM.

In the immediate aftermath of landmark patent law reform, businesses across the country are still deciding who has the most to gain from the passage of the America Invents Act.

The Obama administration is disputing speculation that the drug patent protections being called for in a Transpacific trade deal would drive up medicine costs and effectively reduce the quality of healthcare in underprivileged populations across the globe.

James Pooley, deputy director general of the World Intellectual Property Organization, was selected to deliver a keynote address at the recent Growth, Innovation and Leadership Conference in Silicon Valley.